As of 04 Nov 2026 13:13 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2025/010 (03 Mar 2025): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Desmopressin 10microgram/dose nasal sprayaffected product · inferred from phrasing | Out of stock, as stated | — not stated for this line | notice of 03 Mar 2025 |
| Unlicensed supplies of desmopressin 10microgram/dose nasal sprayunlicensed import named by the source · inferred from phrasing | Stated as available | — not stated for this line | notice of 03 Mar 2025 |
| Desmopressin 100 and 200microgram tablets, desmopressin sublingual tablets and DDAVP Melt oral lyophilisates (60, 120 and 240microgram)named by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 03 Mar 2025 |
| Desmopressin 4microgram/ml injectionnamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 03 Mar 2025 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Unlicensed supplies of desmopressin 10microgram/dose nasal spray — unlicensed import named by the source (inferred from phrasing)
- Desmopressin 100 and 200microgram tablets, desmopressin sublingual tablets and DDAVP Melt oral lyophilisates (60, 120 and 240microgram) — named by the source as remaining available (inferred from phrasing)
- Desmopressin 4microgram/ml injection — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Desmopressin
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
Notified short 3 times on record since 2021 — a recurring shortage spanning 3.3 years. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 03 Mar 2025 | Medicine Supply Notification: Desmopressin 10microgram/dose nasal spray | Supply notification | — | MSN/2025/010 |
| 01 Aug 2024 | Medicine Supply Notification: Desmopressin (DDAVP®) 4 micrograms/1ml solution for injection ampoules | Supply notification | Tier 2 | MSN/2024/081 |
| 08 Nov 2021 | Medicine Supply Notification: Desmopressin (Octim) 150mcg per actuation nasal spray (Ferring Pharmaceuticals) - Updated | Supply notification | — | — |
Also recorded under
Bracketed names seen in this medicine's notice titles: ddavp, octim. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2025)10 Desmopressin 10microgram/dose nasal spray · issued 26 Mar 2025 · valid until early September 2025, as stated · matched by name PDF ↗
- MSAN(2024)45 Desmopressin (DDAVP®) 4 micrograms/1ml solution for injection ampoules · issued 05 Aug 2024 · valid until w/c 16th September, as stated · matched by name PDF ↗
- MSAN(2021)10 Desmopressin (Octim®) 150 micrograms per actuation nasal spray (Ferring · issued 08 Mar 2021 · valid until Q3 of 2023 - update to MSAN(2020)95, as stated · matched by name PDF ↗
- MSAN(2020)101 DDAVP® (Desmopressin) 0.01% w/v (100 micrograms/ml) intranasal solution · issued 21 Oct 2020 · valid until mid-2021, as stated · matched by name PDF ↗
- MSAN(2020)95 Desmopressin (Octim®) 150 micrograms per actuation nasal spray (Ferring · issued 09 Oct 2020 · valid until mid-2021, as stated · matched by name PDF ↗